Profil bibliographique

Herena Eixarch

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

80Publications signalées

1471Citations signalées

2Affiliations récentes

Institutions déclarées

Universitat Autònoma de Barcelona Vall d'Hebron Institut de Recerca

Domaines associés

interferon and immune responsesPARP inhibition in cancer therapyImmune Cell Function and InteractionCancer Immunotherapy and BiomarkersMultiple Sclerosis Research Studies

Publications récentes

Accès ouvert 2026 otherOpenAlex

Figure S6 from Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer

Flaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino, Francesca Mateo et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Table S1 from Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer

Flaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino, Francesca Mateo et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Figure S5 from Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer

Flaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino, Francesca Mateo et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Figure S2 from Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer

Flaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino, Francesca Mateo et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Figure S8 from Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer

Flaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino, Francesca Mateo et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Figure S11 from Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer

Flaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino, Francesca Mateo et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Table S3 from Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer

Flaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino, Francesca Mateo et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Figure S1 from Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer

Flaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino, Francesca Mateo et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Figure S4 from Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer

Flaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino, Francesca Mateo et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Table S2 from Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer

Flaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino, Francesca Mateo et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Figure S9 from Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer

Flaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino, Francesca Mateo et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Figure S7 from Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer

Flaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino, Francesca Mateo et autres

0 citations

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.